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The brain melanocortin system is a primary gateway through which energy balance is controlled. Diano and
colleagues report a novel cellular mechanism mediated via reactive oxygen species (ROS) that regulates the
activity of these melanocortin neurons in response to energy status, thereby modulating appetitive behavior
(Diano et al., 2011).The melanocortin system of the hypotha-
lamic arcuate nucleus (ARC) is a key regu-
lator of energy intake/expenditure, body
weight, and adiposity in animal models
and humans (Farooqi and O’Rahilly,
2008). The central melanocortin pathway
is composed of neurons that express
pro-opiomelanocortin (POMC), the pre-
cursor for the anorectic endogenous
agonist for the melanocortin3 and 4
receptors (MC3R and MC4R, respec-
tively), and functionally antagonistic neu-
rons that express agouti-related protein
(AgRP), the orexigenic endogenous in-
verse agonist for the melanocortin recep-
tors. The crucial role of the melanocortin
system in energy balance is illustrated
not only by the profound metabolic con-
sequences resulting from perturbation of
POMC and MC4R, but also from manipu-
lation of the activity of POMC and AgRP
neurons (Aponte et al., 2011; Farooqi
and O’Rahilly, 2008; Krashes et al.,
2011). Under physiological conditions,
numerous cues of short- and long-term
energy balance regulate the function
of POMC and AgRP neurons, thereby
modulating feeding, energy expenditure,
and body weight (Garfield et al., 2009).
Despite extensive study, the cellular
mechanisms by which neurons of the
melanocortin system sense and respond
to these cues remains incompletely
understood.
A new study by Diano et al. implicates
reactive oxygen species (ROS) in the
regulation of POMC and AgRP neurons
and suggests important physiological
and pathophysiological roles for ROS
in these neurons (Diano et al., 2011)(Figure 1). While ROS are often perceived
as damaging byproducts of intracellular
reactions, an extensive literature demon-
strates the important role of ROS in
intracellular signaling (Valko et al., 2007).
Diano and colleagues build on previous
work from their group implicating ROS in
the inhibition of AgRP neurons (Andrews
et al., 2008). They now provide evidence
that ROS levels are regulated by nutri-
tional cues (such as feeding and leptin,
which increased ROS) in POMC neurons,
and that enhanced ROS in these cells is
associated with neuronal activation and
decreased food intake. Conversely, inhi-
bition of ROS reduced POMC activity,
increased AgRP activity, and stimulated
feeding.
Diano et al. (2011) also report that the
dramatically increased leptin levels in
diet-induced obese (DIO) mice fail to in-
crease ROS levels in POMC cells beyond
those observed in fed lean animals.
Furthermore, peroxisomes, which can
act as ROS scavengers, are increased in
POMC neurons of DIO mice, providing a
potential mechanism for the blunted
ROS response in these obese animals.
The authors propose that this might con-
tribute to the apparent resistance of
POMC neurons to the action of leptin in
obesity. In support of this, inhibiting per-
oxisome proliferator-activated receptor-g
(PPARg) decreased peroxisomes and
increased ROS in the neurons of DIO
mice while increasing POMC neuronal
activation and reducing food intake. In
contrast, PPARg agonists increased
peroxisomes, decreased ROS in POMC
neurons, and increased food intake inCell Metabolism 14,lean mice. This mechanism could con-
tribute to the promotion of feeding and
adiposity by brain PPARg action, espe-
cially in the context of high-fat feeding
(Ryan et al., 2011): increased PPARg
activity in DIO might promote hypotha-
lamic peroxisome proliferation to limit
ROS, decreasing the activity of POMC
neurons and increasing the activity of
AgRP neurons.
This report provides tantalizing new
ideas about a novel cellular mechanism
by which melanocortin neuron activity
may be controlled. For instance, since
numerous growth factors, receptors, and
intracellular processes influence ROS,
ROS levels could integrate the effects of
multiple signals to influence POMC and
AgRP neuronal activity. The findings by
Diano et al. (2011) also raise many ques-
tions for future investigation. Specifically,
it is not clear how leptin (and/or other
nutritional signals) increases ROS. Since
several cytokine receptors related to the
leptin receptor (LEPR-B) increase ROS in
other systems (Valko et al., 2007), it is
possible that LEPR-B signaling could
directly promote ROS accumulation in
POMC neurons. Diano et al. (2011) show
that the nutritional regulation of ROS in
POMC neurons tracks with mitochondrial
number (mitochondria are a major source
of cellular ROS). It is also possible that
altered ROS results from changes in
mitochondrial number and/or function.
Indeed, the signal transducer and acti-
vator of transcription-3 (STAT3; a crucial
effector of leptin action) can reportedly
control oxidative phosphorylation in mito-
chondria directly, independently of itsNovember 2, 2011 ª2011 Elsevier Inc. 573
Figure 1. Proposed Model: ROS Influences Feeding by Regulating the Activity of POMC and
AgRP Neurons
Mitochondria and ROS levels in hypothalamic arcuate nucleus (ARC) POMC neurons are raised in the fed
state compared to the fasted state, suggesting that appetitive state and/or satiety-related signals influ-
ence one or both of their levels. In particular, this increased ROS correlates with, and may be a conse-
quence of, elevated leptin levels and/or the number of mitochondria, a major source of intracellular
ROS. ROS is permissive for firing of POMC neurons and suppression of food intake. Presumably, this
involves the release of the POMC-derived neuropeptide a-melanocyte stimulating hormone (a-MSH),
which acts on melanocortin 4 receptors (MC4R) on downstream neurons in the paraventricular nucleus
of the hypothalamus. In diet-induced obesity (DIO; where leptin sensitivity is compromised), ROS is not
coordinately increased with leptin levels. This may result from proliferation of peroxisomes in POMC
neurons, which can scavenge ROS. DIO increased global hypothalamic expression of the transcription
factor peroxisome proliferator activator-activated receptor-g (PPARg) (presumably at POMC and/or
AgRP neurons), which could drive the increase in peroxisome numbers. Inhibition of PPARg/peroxisome
number in DIO increased ROS and restored satiety signals. Conversely, increasing PPARg/peroxisome
number reduced ROS and increased feeding in lean mice. Many of the intracellular pathways activated
by the leptin receptor (LepR) and/or required for leptin action, including those involving Janus kinase 2
(JAK2), phosphatidylinositol 3-kinase (PI3K), and mitogen-activated protein kinase (MAPK), may be
potentiated by ROS, providing possible mechanisms via which leptin signaling and POMC neuronal
tone could be sensitive to ROS levels. While increased ROS is associated with increased activity of
POMC neurons, increased ROS inhibited the firing of neurons expressing the orexigenic functional antag-
onist of melanocortin receptors agouti-related peptide (AgRP; illustrated), whereas administration of an
ROS scavenger increased the activity of AgRP neurons and stimulated feeding. GABA is a principal medi-
ator of appetitive POMC tone and thereby reflects an important indirect mechanism through which energy
balance signals are relayed to POMC. Dashed lines, presumed; solid lines, known or demonstrated.
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Previewstranscriptional function (Gough et al.,
2009).
It is also possible that increased firing
of POMC neurons in response to signals
such as leptin might promote mitochon-
drial accumulation and ROS production
secondary to increased metabolic de-
mand. Diano et al. (2011) show that chem-
ical manipulation of ROS acutely modu-
lates POMC and AgRP membrane
potential and firing in slice preparations,
however, consistent with the notion that
ROS directly influences POMC and
AgRP neuronal activity. A number of
mechanisms could underlie the control
of neuronal activity by ROS, including574 Cell Metabolism 14, November 2, 2011 ªthe cell-autonomous interaction of ROS
with the LEPR-B signaling pathway. In-
deed, in other systems, ROS have been
shown to activate multiple intracellular
cellular signaling pathways that are
known to lie downstream of LEPR-B
(Valko et al., 2007).
As cell-specific modulation of ROS is
not technically straightforward, this study
employedmainly pharmacological agents
that globally increased or decreased ROS
levels and/or peroxisome numbers in the
brain. It is therefore difficult to determine
the contribution of direct effects on
POMC and AgRP neurons relative to indi-
rect effects mediated by altered inputs2011 Elsevier Inc.from other neurons to these melano-
cortin cells. Indeed, since much of the
physiological regulation of Pomc expres-
sion and neuronal activity may be medi-
ated via modulation of an inhibitory
GABAergic input onto POMC neurons,
even the effect of leptin on ROS need
not be cell autonomous (Vong et al.,
2011). While the precise, cell-selective
manipulation of ROS levels remains chal-
lenging, this will be required to discrimi-
nate direct from indirect effects. The
cell-autonomous genetic manipulation of
PPARg in the neurons of the melanocortin
system provides one tractable method to
further probe this.
Overall, the results of Diano et al. (2011)
reveal an important new mechanism by
which mitochondria, peroxisomes, and
ROS interact to regulate ARC melanocor-
tin tone and energy balance. While there
remain many details to be clarified, unrav-
eling the specific role of these cellular
processes in energy homeostasis will
undoubtedly be exciting and have impor-
tant implications for metabolic health and
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